Current status of the diagnosis and treatment of chronic hepatitis B virus infection with immune control / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 1134-1137, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-822001
ABSTRACT
Patients with chronic hepatitis B virus (HBV) infection with immune control generally have no or little liver damage, with a low incidence rate of adverse events, and spontaneous HBsAg seroclearance may occur in some patients. Most scholars do not recommend antiviral therapy for such patients in China and foreign countries. However, with the gradual aging of chronic HBV infection, patients with immune control are also faced with disease progression and the development of liver cirrhosis or liver cancer. This article introduces the clinical significance of appropriate timing of antiviral therapy for the prognosis of patients with chronic HBV infection with immune control.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
Idioma:
Chino
Revista:
Journal of Clinical Hepatology
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS